Skip to main content

Pennsylvania pauses administration of Johnson & Johnson Covid-19 vaccine

The decision comes following recommendations from the CDC and FDA after there were six reported cases of rare blood clots in women aged 18 to 46 who received the Johnson & Johnson vaccine out of the nearly 7 million of these doses administered nationwide.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.